» Articles » PMID: 23884013

Assisted Bicycle Training Delays Functional Deterioration in Boys with Duchenne Muscular Dystrophy: the Randomized Controlled Trial "no Use is Disuse"

Overview
Publisher Sage Publications
Date 2013 Jul 26
PMID 23884013
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Physical training might delay the functional deterioration caused by disuse in boys with Duchenne muscular dystrophy (DMD). The "No Use Is Disuse" study is the first explorative, randomized controlled trial in boys with DMD to examine whether assisted bicycle training is feasible, safe, and beneficial.

Methods: Ambulatory and recently wheelchair-dependent boys with DMD were allocated to the intervention or control group. The intervention group received assisted bicycle training of the legs and arms during 24 weeks. The control group received the same training after a waiting period of 24 weeks. The primary study outcomes were the Motor Function Measure (MFM) and the Assisted 6-Minute Cycling Test (A6MCT). Group differences were examined by an analysis of covariance.

Results: Thirty boys (mean age 10.5 ± 2.6 years, 18 ambulant and 12 wheelchair-dependent) were allocated to the intervention (n = 17) or the control (n = 13) group. All boys in the intervention group (except one) completed the training. After 24 weeks, the total MFM score remained stable in the intervention group, whereas it had significantly decreased in the control group (Δ = 4.9, 95% confidence interval = 2.2-7.6). No significant group differences were found for the A6MCT. No serious adverse events were observed.

Conclusions: Our results suggest that assisted bicycle training of the legs and arms is feasible and safe for both ambulant and wheelchair-dependent children and may decline the deterioration due to disuse. Progressive deterioration, however, may compromise the design of trials for DMD.

Citing Articles

Inspiratory muscle training in children with neuromuscular disorders.

Human A, Corten L, Lozano-Ray E, Morrow B S Afr J Physiother. 2024; 80(1):2055.

PMID: 39229292 PMC: 11369745. DOI: 10.4102/sajp.v80i1.2055.


Pragmatic Neurorehabilitation Approach for Improving Quality of Life in Duchenne Muscular Dystrophy: A Case Report.

Nangliya R, Sasun A, Samal S Cureus. 2024; 16(3):e56315.

PMID: 38629006 PMC: 11020631. DOI: 10.7759/cureus.56315.


Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.

McDonald C, Camino E, Escandon R, Finkel R, Fischer R, Flanigan K J Neuromuscul Dis. 2024; 11(2):499-523.

PMID: 38363616 PMC: 10977441. DOI: 10.3233/JND-230219.


Design requirements of upper extremity supports for daily use in Duchenne muscular dystrophy with severe muscle weakness.

Filius S, Harlaar J, Alberts L, Houwen-van Opstal S, van der Kooij H, Janssen M J Rehabil Assist Technol Eng. 2024; 11:20556683241228478.

PMID: 38344392 PMC: 10854382. DOI: 10.1177/20556683241228478.


Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA).

Tang W, Gu B, Montalvo S, Dunaway Young S, Parker D, de Monts C J Clin Med. 2023; 12(24).

PMID: 38137651 PMC: 10743820. DOI: 10.3390/jcm12247582.